文献速递心境障碍

抑郁症与抗抑郁药反应生物标志物:淋巴母细胞系中SSRIs与n-3多不饱和脂肪酸的作用

Potential depression and antidepressant-response biomarkers in human lymphoblast cell lines from treatment-responsive and treatment-resistant subjects: roles of SSRIs and omega-3 polyunsaturated fatty acids.
PubMed 文献 · Mol Psychiatry · 2020-04-23

研究利用正常和抑郁受试者(分为缓解者与未缓解者)的淋巴母细胞系,检测生长因子、细胞因子及cAMP生成系统相关基因与蛋白表达。抑郁受试者细胞中VEGFA和BDNF基因显著下调,n-3多不饱和脂肪酸与艾司西酞普兰可增加腺苷酸环化酶和BDNF基因表达。淋巴母细胞对n-3多不饱和脂肪酸的cAMP反应与神经元/胶质细胞相反,但患者来源淋巴母细胞携带潜在抑郁生物标志物。

要点

  • 抑郁受试者淋巴母细胞中VEGFA和BDNF基因表达显著下调。
  • n-3多不饱和脂肪酸与艾司西酞普兰增加淋巴母细胞腺苷酸环化酶和BDNF基因表达。
  • 淋巴母细胞对n-3多不饱和脂肪酸的cAMP反应与神经元/胶质细胞相反,但可用于精准医学研究。

核心结论

  • 患者来源淋巴母细胞系携带潜在的抑郁症生物标志物,可用于研究抑郁症精准医学。
  • n-3多不饱和脂肪酸与SSRIs在淋巴母细胞中增加腺苷酸环化酶和BDNF基因表达,支持其抗抑郁作用的临床观察。

研究设计与样本

  • 研究使用来自正常受试者和抑郁受试者(分为缓解者与未缓解者)的库存人淋巴母细胞系。
  • 检测了与神经内分泌和炎症功能相关的信号级联的基因和蛋白表达谱。

主要发现

  • 三组淋巴母细胞系在神经内分泌和炎症功能相关的信号级联的初始基因和蛋白表达谱存在差异。
  • 抑郁受试者细胞中生长因子基因VEGFA和BDNF显著下调。
  • n-3多不饱和脂肪酸和艾司西酞普兰处理增加淋巴母细胞中腺苷酸环化酶和BDNF基因表达。
  • 与神经元和胶质细胞中的观察相反,n-3多不饱和脂肪酸处理减弱淋巴母细胞中cAMP积累。

临床怎么用

  • 患者来源淋巴母细胞系可作为研究抑郁症精准医学的重要工具。
  • n-3多不饱和脂肪酸与SSRIs可能具有相加的抗抑郁作用,支持n-3多不饱和脂肪酸用于抑郁症治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

While several therapeutic strategies exist for depression, most antidepressant drugs require several weeks before reaching full biochemical efficacy and remission is not achieved in many patients. Therefore, biomarkers for depression and drug-response would help tailor treatment strategies. This study made use of banked human lymphoblast cell lines (LCLs) from normal and depressed subjects; the latter divided into remitters and non-remitters. Due to the fact that previous studies have shown effects on growth factors, cytokines, and elements of the cAMP-generating system as potential biomarkers for depression and antidepressant action, these were examined in LCLs. Initial gene and protein expression profiles for signaling cascades related to neuroendocrine and inflammatory functions differ among the three groups. Growth factor genes, including VEGFA and BDNF were significantly down-regulated in cells from depressed subjects. In addition, omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been reported to act as both antidepressants and anti-inflammatories, but the mechanisms for these effects are not established. Here we showed that n-3 PUFAs and escitalopram (selective serotonin reuptake inhibitors, SSRIs) treatment increased adenylyl cyclase (AC) and BDNF gene expression in LCLs. These data are consistent with clinical observations showing that n-3 PUFA and SSRI have antidepressant affects, which may be additive. Contrary to observations made in neuronal and glial cells, n-3 PUFA treatment attenuated cAMP accumulation in LCLs. However, while lymphoblasts show paradoxical responses to neurons and glia, patient-derived lymphoblasts appear to carry potential depression biomarkers making them an important tool for studying precision medicine in depressive patients. Furthermore, these data validate usefulness of n-3 PUFAs in treatment for depression.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chukaew P, Leow A, Saengsawang W, et al. Potential depression and antidepressant-response biomarkers in human lymphoblast cell lines from treatment-responsive and treatment-resistant subjects: roles of SSRIs and omega-3 polyunsaturated fatty acids. Mol Psychiatry. 2020. PMID: 32327735. doi:10.1038/s41380-020-0724-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。